Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Other Accumulated Expenses (2016 - 2023)

Historic Other Accumulated Expenses for Perspective Therapeutics (CATX) over the last 13 years, with Q4 2023 value amounting to $480000.0.

  • Perspective Therapeutics' Other Accumulated Expenses fell 1593.7% to $480000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $480000.0, marking a year-over-year decrease of 1593.7%. This contributed to the annual value of $480000.0 for FY2023, which is 1593.7% down from last year.
  • Per Perspective Therapeutics' latest filing, its Other Accumulated Expenses stood at $480000.0 for Q4 2023, which was down 1593.7% from $24000.0 recorded in Q3 2023.
  • In the past 5 years, Perspective Therapeutics' Other Accumulated Expenses ranged from a high of $571000.0 in Q4 2022 and a low of $15000.0 during Q1 2023
  • Over the past 5 years, Perspective Therapeutics' median Other Accumulated Expenses value was $96500.0 (recorded in 2020), while the average stood at $127300.0.
  • As far as peak fluctuations go, Perspective Therapeutics' Other Accumulated Expenses surged by 45436.89% in 2022, and later crashed by 8404.26% in 2023.
  • Perspective Therapeutics' Other Accumulated Expenses (Quarter) stood at $89000.0 in 2019, then grew by 13.48% to $101000.0 in 2020, then grew by 1.98% to $103000.0 in 2021, then soared by 454.37% to $571000.0 in 2022, then dropped by 15.94% to $480000.0 in 2023.
  • Its Other Accumulated Expenses stands at $480000.0 for Q4 2023, versus $24000.0 for Q3 2023 and $20000.0 for Q2 2023.